ASO biotech wants MHRA to go further in new rare disease therapy framework
By
Millie Hoe
25d agoen
Source
bioprocessintl.comASO biotech wants MHRA to go further in new rare disease therapy frameworkbioprocessintl.comCEO of SynaptixBio thinks the MHRA could do more to support UK rare disease drug innovation.
You might also wanna read
New cancer drug trial offers hope for patients with rare aggressive tumour
Reading Chronicle·1d ago

New drug for cancer patients with ‘limited’ treatment options enters clinical trial
The Independent·2d ago
UK Government Considers New Regulations for AI-Powered Medical Devices in Healthcare
The UK government is considering new proposals for regulating AI-powered medical devices in healthcare. The Medicines and Healthcare product
AI accelerates search for motor neurone disease treatments by repurposing existing drugs
Researchers are using AI to accelerate the search for drugs to treat motor neurone disease (MND). By repurposing existing approved drugs, th
China creates new regulatory pathway to accelerate access to advanced biomedical therapies
China has established a new regulatory "tech track" for advanced therapies like personalized cancer treatments, cell and gene therapies, and

STAT+: Pharmalittle: We’re reading about a Novartis acquisition, Republicans backing clinical trial diversity, and more
STAT·2d ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.